[
  {
    "date": "2023-12-30",
    "symbol": "ONCY",
    "period": "FY",
    "documenttype": "20-F",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documentperiodenddate": "2023-12-31",
    "currentfiscalyearenddate": "--12-31",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-38512",
    "entityregistrantname": "ONCOLYTICS BIOTECH INC.",
    "entityincorporationstatecountrycode": "A0",
    "entityaddressaddressline1": "804, 322 11th Avenue SW",
    "entityaddresscityortown": "Calgary",
    "entityaddressstateorprovince": "AB",
    "entityaddresscountry": "CA",
    "entityaddresspostalzipcode": "T2R 0C5",
    "contactpersonnelname": "Kirk Look",
    "cityareacode": 403,
    "localphonenumber": "670-7377",
    "contactpersonnelemailaddress": "info@oncolytics.ca",
    "security12btitle": "no",
    "tradingsymbol": "ONCY",
    "securityexchangename": "NASDAQ",
    "entitycommonstocksharesoutstanding": 74423960,
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Accelerated Filer",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "documentfinstmterrorcorrectionflag": "false",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1129928,
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "auditorfirmid": 1263,
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "Calgary, Canada",
    "cashandcashequivalents": 34912000,
    "othercurrentreceivables": 15000,
    "currentprepayments": 3246000,
    "currentassets": 38173000,
    "propertyplantandequipment": 282000,
    "rightofuseassets": 365000,
    "assets": 38820000,
    "tradeandothercurrentpayables": 3572000,
    "othercurrentliabilities": 332000,
    "currentleaseliabilities": 133000,
    "currentderivativefinancialliabilities": 200000,
    "currentliabilities": 4237000,
    "noncurrentcontractliabilities": 6730000,
    "noncurrentleaseliabilities": 290000,
    "liabilities": 11257000,
    "issuedcapital": 430906000,
    "additionalpaidincapital": 42116000,
    "accumulatedothercomprehensiveincome": 544000,
    "retainedearnings": -446003000,
    "equity": 27563000,
    "equityandliabilities": 38820000,
    "numberofsharesissued": 74423960,
    "researchanddevelopmentexpense": 17709000,
    "generalandadministrativeexpense": 16082000,
    "profitlossfromoperatingactivities": -33791000,
    "gainslossesonchangeinfairvalueofderivatives": 5285000,
    "gainslossesonexchangedifferencesontranslationrecognisedinprofitorloss": -475000,
    "interestincomeoncashandcashequivalents": 1326000,
    "profitlossbeforetax": -27655000,
    "incometaxexpensecontinuingoperations": 97000,
    "profitloss": -27752000,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": -118000,
    "comprehensiveincome": -27870000,
    "basicearningslosspershare": -0.41,
    "dilutedearningslosspershare": -0.41,
    "weightedaverageshares": 67624036,
    "adjustedweightedaverageshares": 67624036,
    "increasedecreasethroughexerciseofoptions": 1271000,
    "issueofequity": 10676000,
    "shareissuerelatedcost": 2805000,
    "increasedecreasethroughsharebasedpaymenttransactions": 1917000,
    "adjustmentsfordepreciationandamortisationexpense": 81000,
    "adjustmentsfordepreciationrightofuseassets": 322000,
    "adjustmentsforsharebasedpayments": 1917000,
    "expensefromequitysettledsharebasedpaymenttransactionsinwhichgoodsorservicesreceiveddidnotqualifyforrecognitionasassets": 151000,
    "interestrevenueexpense": -71000,
    "adjustmentsforunrealisedforeignexchangelossesgains": 282000,
    "adjustmentsforgainslossesonchangeinfairvalueofderivatives": 5285000,
    "increasedecreaseinworkingcapital": -1765000,
    "cashflowsfromusedinoperations": -28448000,
    "proceedsfromsalesormaturityoffinancialinstrumentsclassifiedasinvestingactivities": 20230000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 8000,
    "cashflowsfromusedininvestingactivities": 20222000,
    "proceedsfromexerciseofoptions": 781000,
    "proceedsfromissuingshares": 10261000,
    "cashoutflowforleases": 407000,
    "cashflowsfromusedinfinancingactivities": 31994000,
    "increasedecreaseincashandcashequivalents": 23768000,
    "effectofexchangeratechangesoncashandcashequivalents": -522000,
    "disclosureofeconomicdependencetextblock": "Economic Dependence",
    "descriptionofaccountingpolicyfordeterminingcomponentsofcashandcashequivalentsandmarketablesecuritiespolicytextblock": "Cash and cash equivalents and marketable securitiesCash equivalents include interest-bearing deposits with our bank totaling $31,534 as at December 31, 2023 (December 31, 2022 - $9,501). Marketable securities include foreign currency term deposits with a maturity of greater than 90 days and less than one year.",
    "detaileddisclosureoftradeandotherpayablesexplanatorytabletextblock": "December 31, 2023December 31, 2022Trade payables$1,082 $2,252 Accrued liabilities2,490 1,398 $3,572 $3,650",
    "disclosureofquantitativeinformationaboutleaseliabilitiestextblock": "The following table summarizes our lease liabilities activity for the years ended December 31:                  20232022As at beginning of year$373 $655 Additions392 — Payment of lease liabilities(407)(381)Interest expense on lease liabilities71 80 Foreign exchange impact(6)19 As at end of year$423 $373",
    "disclosureofcapitalcomponentstabletextblock": "December 31, 2023December 31, 2022Cash and cash equivalents$34,912 $11,666 Marketable securities$— $20,472 Shareholders' equity$27,563 $26,502",
    "scheduleofforeigncurrencyheldtabletextblock": "Significant balances in foreign currencies as at December 31, 2023, were as follows:U.S. dollarCash and cash equivalents$24,294 Accounts payable and accrued liabilities(1,476)$22,818",
    "cashflowoperatingcapital1tabletextblock": "Net Change In Non-Cash Working Capital202320222021Change in:   Other receivables$506 $345 $(776)Prepaid expenses777 (1,247)(349)Accounts payable and accrued liabilities(78)1,662 183 Other liabilities332 (352)228 Non-cash impact of foreign exchange228 (17)(194)Change in non-cash working capital related to operating activities$1,765 $391 $(908)",
    "scheduleofcashflowsupplementaldisclosures1tabletextblock": "Other Cash Flow Disclosures202320222021Cash interest received$1,554 $452 $190 Cash taxes paid$120 $46 $35",
    "otherexpensesandadjustmentstabletextblock": "202320222021Research and development expensesClinical trial expenses$3,675 $4,970 $3,205 Manufacturing & related process development expenses5,789 2,148 1,547 Intellectual property expenses397 544 618 Translational science expenses— 264 673 Personnel-related expenses6,324 6,023 4,754 Share-based compensation expense1,305 1,371 2,087 Other expenses219 112 36 $17,709 $15,432 $12,920",
    "cashandcashequivalentsandcurrentinvestments": 34912000,
    "cashequivalents": 31534000,
    "numberofstockoptionplans": 1,
    "maximumtermofoptionsgrantedforsharebasedpaymentarrangement": "P10Y",
    "propertyplantandequipmentannualdepreciationrate": 0.2,
    "otherreceivables": 5000000,
    "currentprepaidexpenses": 1319000,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 7000,
    "depreciationpropertyplantandequipment": 2000,
    "tradeandothercurrentpayablestotradesuppliers": 1082000,
    "accrualsclassifiedascurrent": 2490000,
    "operatingleaseremainingleaseterm": "P3Y",
    "weightedaveragelesseesincrementalborrowingrateappliedtoleaseliabilitiesrecognisedatdateofinitialapplicationofifrs16": 0.15,
    "additionstorightofuseassets": 392000,
    "increasethroughnewleasesliabilitiesarisingfromfinancingactivities": 392000,
    "depreciationrightofuseassets": 322000,
    "foreignexchangeimpactrightofuseassets": -1000,
    "leaseliabilities": 423000,
    "interestexpenseonleaseliabilities": 71000,
    "gainslossesfromforeignexchangeimpact": -6000,
    "grossleaseliabilities": 202000,
    "numberofwarrantsoutstanding": 7731085,
    "issueofequityshares": 7667050,
    "warrantliabilityunamortizeddiscount": 1822000,
    "warrantliabilityamortizeddiscount": 146000,
    "proceedsfromissueofunitsgross": 10676000,
    "sharesissuedpricepershare1": 2.14,
    "expirationperiodofotherequityinstrumentsgrantedinsharebasedpaymentarrangement": "P60M",
    "warrantliability": 7360000,
    "warrantsterm": "P5Y",
    "weightedaveragesharepriceotherequityinstrumentsgranted": 2.28,
    "riskfreeinterestrateotherequityinstrumentsgranted": 0.038,
    "otherequityinstrumentslifeotherequityinstrumentsgranted": 5,
    "expectedvolatilityotherequityinstrumentsgranted": 0.365,
    "weightedaveragefairvaluepriceatmeasurementdateotherequityinstrumentsgranted": 0.88,
    "proceedsfromissueofordinaryshares": 10356000,
    "shareissuerelatedcostcommissions": 320000,
    "issueofequitysharesnumberofcommonshares": 1,
    "numberofinstrumentsotherequityinstrumentsgranted": 536693,
    "sharewarrantsissuedtransactioncosts": 3130000,
    "expensefromsharebasedpaymenttransactionswithpartiesotherthanemployees": 638000,
    "sharewarrantsissuedoperatingexpense": 740000,
    "numberofsharesreservedforissueunderoptionsandcontractsforsaleofsharespercentageofcommonsharesmaximum": 0.14,
    "sharesreservedforissueunderoptionsandcontractsforsaleofshares": 10419354,
    "expensefromsharebasedpaymenttransactionswithemployees": 1917000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P1Y",
    "weightedaverageexercisepriceofotherequityinstrumentsgrantedinsharebasedpaymentarrangement2019": 2.25,
    "numberofoutstandingshareoptions": 7063333,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 2145400,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": 280288,
    "numberofshareoptionsexpiredinsharebasedpaymentarrangement": 314573,
    "numberofshareoptionsexercisedinsharebasedpaymentarrangement": 450391,
    "numberofshareoptionsexercisableinsharebasedpaymentarrangement": 5039604,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 2.72,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 2.23,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement2019": 2.86,
    "weightedaverageexercisepriceofshareoptionsexpiredinsharebasedpaymentarrangement2019": 4.17,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentarrangement2019": 1.74,
    "weightedaverageexercisepriceofshareoptionsexercisableinsharebasedpaymentarrangement2019": 2.85,
    "exercisepriceofoutstandingshareoptions2019": 1.14,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": "P3Y8M12D",
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.041,
    "descriptionofoptionlifeshareoptionsgranted": 3,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.72,
    "weightedaveragefairvalueatmeasurementdateshareoptionsgranted": 1.12,
    "numberofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement": 398440,
    "numberofotherequityinstrumentsforfeitedinsharebasedpaymentarrangement": 4760,
    "weightedaveragefairvalueatmeasurementdateotherequityinstrumentsgranted": 2.23,
    "contractliabilityrecognitionperiod": "P5Y",
    "contractliabilities": 6730000,
    "purchaseobligation1": 12686000,
    "purchaseobligationcommitmentterm": "P3Y",
    "leasenotyetcommencedpayments": 1098000,
    "leasenotyetcommencedterm": "P5Y3M18D",
    "accountingprofit": -27655000,
    "applicabletaxrate": 0.23,
    "taxexpenseincomeatapplicabletaxrate": -6361000,
    "taxeffectofforeigntaxrates": 2841000,
    "taxeffectofstockbasedcompensation": -441000,
    "taxeffectoftaxpools": 2000,
    "taxeffectfromchangeintaxrate": -9088000,
    "othertaxeffectsforreconciliationbetweenaccountingprofitandtaxexpenseincome": 325000,
    "taxeffectofexpirationoftaxbenefits": 3382000,
    "taxeffectofchangeinfairvalueofwarrantderivative": -1215000,
    "valuationallowancedeferredtaxassetincreasedecreaseamount1": -9770000,
    "currenttaxexpenseincome": 97000,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 110450000,
    "unusedtaxcreditsforwhichnodeferredtaxassetrecognised": 4056000,
    "deductibletemporarydifferencesforwhichnodeferredtaxassetisrecognised": 37174000,
    "sensitivityanalysisfortypesofmarketriskreasonablypossiblechangeinriskvariableamount": 0.01,
    "sensitivityanalysisfortypesofmarketriskreasonablypossiblechangeinriskvariableimpactonpretaxearnings": -140000,
    "balanceheldinforeigncurrencynet": 22818000,
    "adjustmentsfordecreaseincreaseinotheroperatingreceivables": 506000,
    "adjustmentsfordecreaseincreaseinprepaidexpenses": 777000,
    "adjustmentsforincreasedecreaseintradeandotherpayables": -78000,
    "adjustmentsforincreasedecreaseinotheroperatingpayables": 332000,
    "increasedecreasethroughforeignexchangefinancialassetsliabilitiesnet": 228000,
    "proceedsfrominterestreceived": 1554000,
    "incometaxespaidrefund": 120000,
    "concentrationrisknumber": 1,
    "clinicaltrialexpense": 3675000,
    "manufacturingexpense": 5789000,
    "intellectualpropertyexpense": 397000,
    "otheremployeeexpense": 6324000,
    "miscellaneousotheroperatingexpense": 219000,
    "publiccompanyexpense": 11278000,
    "officeexpenses": 3789000,
    "amortisationexpense": 81000,
    "employeebenefitsexpense": 6324000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 4870000,
    "keymanagementpersonnelcompensationterminationbenefits": 319000,
    "keymanagementpersonnelcompensationsharebasedpayment": 1496000,
    "keymanagementpersonnelcompensation": 6685000
  },
  {
    "date": "2022-12-31",
    "symbol": "ONCY",
    "period": "FY",
    "documenttype": "20-F",
    "documentregistrationstatement": "o",
    "documentannualreport": "true",
    "documentperiodenddate": "December 31, 2022",
    "currentfiscalyearenddate": "December 31",
    "documenttransitionreport": "o",
    "documentshellcompanyreport": "o",
    "entityfilenumber": "001-38512",
    "entityregistrantname": "ONCOLYTICS BIOTECH INC.",
    "entityincorporationstatecountrycode": "A0",
    "entityaddressaddressline1": "804, 322 11th Avenue SW",
    "entityaddresscityortown": "Calgary",
    "entityaddressstateorprovince": "Alberta",
    "entityaddresscountry": "Canada",
    "entityaddresspostalzipcode": "T2R 0C5",
    "contactpersonnelname": "Kirk Look",
    "cityareacode": 403,
    "localphonenumber": "670-7377",
    "contactpersonnelemailaddress": "info@oncolytics.ca",
    "security12btitle": "no",
    "tradingsymbol": "ONCY",
    "securityexchangename": "Nasdaq",
    "entitycommonstocksharesoutstanding": 61327914,
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated filer",
    "entityemerginggrowthcompany": "FALSE",
    "icfrauditorattestationflag": "o",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "entityshellcompany": "o",
    "entitycentralindexkey": 1129928,
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "auditorfirmid": 1263,
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "Calgary, Canada",
    "cashandcashequivalents": 6635000,
    "currentfinancialassetsavailableforsale": 20472000,
    "othercurrentreceivables": 521000,
    "currentprepayments": 3025000,
    "currentassets": 35684000,
    "propertyplantandequipment": 83000,
    "rightofuseassets": 296000,
    "noncurrentprepayments": 998000,
    "assets": 37334000,
    "tradeandothercurrentpayables": 1035000,
    "currentleaseliabilities": 216000,
    "currentderivativefinancialliabilities": 79000,
    "currentliabilities": 3945000,
    "noncurrentcontractliabilities": 6730000,
    "noncurrentleaseliabilities": 157000,
    "liabilities": 10832000,
    "issuedcapital": 404040000,
    "additionalpaidincapital": 40051000,
    "accumulatedothercomprehensiveincome": 662000,
    "retainedearnings": -418251000,
    "equity": 404040000,
    "equityandliabilities": 37334000,
    "numberofsharesissued": 61327914,
    "researchanddevelopmentexpense": 15432000,
    "operatingexpense": 11492000,
    "profitlossfromoperatingactivities": -26924000,
    "gainslossesonchangeinfairvalueofderivatives": -20000,
    "gainslossesonexchangedifferencesontranslationrecognisedinprofitorloss": 1665000,
    "interestincomeoncashandcashequivalents": 528000,
    "profitlossbeforetax": -24751000,
    "incometaxexpensecontinuingoperations": 84000,
    "profitloss": -24835000,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": 274000,
    "comprehensiveincome": -24835000,
    "basicearningslosspershare": -0.43,
    "dilutedearningslosspershare": -0.43,
    "weightedaverageshares": 58029745,
    "adjustedweightedaverageshares": 58029745,
    "increasedecreasethroughexerciseofoptions": 12000,
    "increasedecreasethroughincentiveshareawardsequity": -98000,
    "increasedecreasethroughexpirationofwarrantequity": 3618000,
    "issueofequity": 13338000,
    "increasedecreasethroughsharebasedpaymenttransactions": 2378000,
    "shareissuerelatedcost": 555000,
    "adjustmentsfordepreciationandamortisationexpense": 93000,
    "adjustmentsfordepreciationrightofuseassets": 299000,
    "adjustmentsforsharebasedpayments": 2378000,
    "interestrevenueexpense": 76000,
    "adjustmentsforunrealisedforeignexchangelossesgains": -1625000,
    "increasedecreaseinworkingcapital": -391000,
    "cashflowsfromusedinoperations": -23355000,
    "purchaseoffinancialinstrumentsclassifiedasinvestingactivities": 20348000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 55000,
    "cashflowsfromusedininvestingactivities": -20403000,
    "proceedsfromexerciseofoptions": 12000,
    "proceedsfromissuingshares": 12574000,
    "cashoutflowforleases": 381000,
    "cashflowsfromusedinfinancingactivities": 12205000,
    "increasedecreaseincashandcashequivalents": -31553000,
    "effectofexchangeratechangesoncashandcashequivalents": 1957000,
    "cashandcashequivalentsandcurrentinvestments": 32138000,
    "cashequivalents": 9501000,
    "numberofstockoptionplans": 1,
    "maximumtermofoptionsgrantedforsharebasedpaymentarrangement": "ten years",
    "propertyplantandequipmentannualdepreciationrate": 0.3,
    "otherreceivables": 360000,
    "currentprepaidexpenses": 1327000,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 57000,
    "depreciationpropertyplantandequipment": 93000,
    "tradeandothercurrentpayablestotradesuppliers": 2252000,
    "accrualsclassifiedascurrent": 1398000,
    "operatingleaseremainingleaseterm": 6,
    "depreciationrightofuseassets": 299000,
    "foreignexchangeimpactrightofuseassets": 11000,
    "leaseliabilities": 373000,
    "interestexpenseonleaseliabilities": 80000,
    "gainslossesfromforeignexchangeimpact": 19000,
    "grossleaseliabilities": 447000,
    "issueofequityshares": 3515462,
    "grossproceedsfromissueofordinaryshares": 5632000,
    "sharesissuedpricepershare1": 1.6,
    "shareissuerelatedcostcommissions": 169000,
    "proceedsfromissueofordinaryshares": 5463000,
    "classofwarrantorrightoutstanding1": 64035,
    "numberofsharesexpired": 16443500,
    "warrantsandrightsexpired": 3618000,
    "numberofoutstandingshareoptions": 310614,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 1005000,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": 62962,
    "numberofshareoptionsexpiredinsharebasedpaymentarrangement": 304940,
    "numberofshareoptionsexercisedinsharebasedpaymentarrangement": 8333,
    "numberofshareoptionsexercisableinsharebasedpaymentarrangement": 310614,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 7.39,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 2.04,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement2019": 3.83,
    "weightedaverageexercisepriceofshareoptionsexpiredinsharebasedpaymentarrangement2019": 10.8,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentarrangement2019": 1.45,
    "weightedaverageexercisepriceofshareoptionsexercisableinsharebasedpaymentarrangement2019": 7.39,
    "exercisepriceofoutstandingshareoptions2019": 27.46,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": 2.54,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "three-year",
    "sharesreservedforissueunderoptionsandcontractsforsaleofshares": 6132791,
    "expensefromsharebasedpaymenttransactionswithemployees": 1007000,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.0335,
    "descriptionofoptionlifeshareoptionsgranted": 3,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.9601999999999999,
    "weightedaveragefairvalueatmeasurementdateshareoptionsgranted": 1.24,
    "numberofotherequityinstrumentsexercisedorvestedinsharebasedpaymentarrangement": 40560,
    "contractliabilityrecognitionperiod": "five years",
    "contractliabilities": 6730000,
    "purchaseobligation1": 16775000,
    "purchaseobligationcommitmentterm": "three years",
    "accountingprofit": -24751000,
    "applicabletaxrate": 0.23,
    "taxexpenseincomeatapplicabletaxrate": -5693000,
    "taxeffectofforeigntaxrates": 3552000,
    "taxeffectofstockbasedcompensation": -547000,
    "taxeffectoftaxpools": -338000,
    "othertaxeffectsforreconciliationbetweenaccountingprofitandtaxexpenseincome": -368000,
    "taxeffectofexpirationoftaxbenefits": 1614000,
    "taxeffectofchangeinfairvalueofwarrantderivative": 5000,
    "valuationallowancedeferredtaxassetincreasedecreaseamount1": -765000,
    "currenttaxexpenseincome": 84000,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 145405000,
    "unusedtaxcreditsforwhichnodeferredtaxassetrecognised": 1285000,
    "deductibletemporarydifferencesforwhichnodeferredtaxassetisrecognised": 38627000,
    "sensitivityanalysisfortypesofmarketriskreasonablypossiblechangeinriskvariableamount": 0.01,
    "sensitivityanalysisfortypesofmarketriskreasonablypossiblechangeinriskvariableimpactonpretaxearnings": 22000,
    "financialassetsavailableforsale": 15115000,
    "balanceheldinforeigncurrencynet": -1035000,
    "adjustmentsfordecreaseincreaseinotheroperatingreceivables": 345000,
    "adjustmentsfordecreaseincreaseinprepaidexpenses": -1247000,
    "adjustmentsforincreasedecreaseintradeandotherpayables": 1662000,
    "adjustmentsforincreasedecreaseinotheroperatingpayables": -352000,
    "increasedecreasethroughforeignexchangefinancialassetsliabilitiesnet": -17000,
    "proceedsfrominterestreceived": 452000,
    "incometaxespaidrefund": 46000,
    "concentrationrisknumber": 1,
    "clinicaltrailexpense": 4970000,
    "manufacturingexpense": 2148000,
    "intellectualpropertyexpense": 544000,
    "translationalscienceexpense": 264000,
    "otheremployeeexpense": 6023000,
    "miscellaneousotheroperatingexpense": 112000,
    "publiccompanyexpense": 6790000,
    "officeexpenses": 3303000,
    "amortisationexpense": 93000,
    "generalandadministrativeexpense": 11492000,
    "employeebenefitsexpense": 2870000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 4308000,
    "keymanagementpersonnelcompensationsharebasedpayment": 1615000,
    "keymanagementpersonnelcompensation": 5923000
  },
  {
    "date": "2021-12-31",
    "symbol": "ONCY",
    "period": "FY",
    "documenttype": "20-F",
    "documentregistrationstatement": "o",
    "documentannualreport": "true",
    "documentperiodenddate": "December 31, 2021",
    "currentfiscalyearenddate": "December 31",
    "documenttransitionreport": "o",
    "documentshellcompanyreport": "o",
    "entityfilenumber": "001-38512",
    "entityregistrantname": "ONCOLYTICS BIOTECH INC.",
    "entityincorporationstatecountrycode": "A0",
    "entityaddressaddressline1": "804, 322 11th Avenue SW",
    "entityaddresscityortown": "Calgary",
    "entityaddressstateorprovince": "Alberta",
    "entityaddresscountry": "Canada",
    "entityaddresspostalzipcode": "T2R 0C5",
    "contactpersonnelname": "Kirk Look",
    "cityareacode": 403,
    "localphonenumber": "670-7377",
    "contactpersonnelemailaddress": "info@oncolytics.ca",
    "security12btitle": "no",
    "tradingsymbol": "ONCY",
    "securityexchangename": "Nasdaq",
    "entitycommonstocksharesoutstanding": 55043789,
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Accelerated filer",
    "entityemerginggrowthcompany": "FALSE",
    "icfrauditorattestationflag": "true",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "entityshellcompany": "o",
    "entitycentralindexkey": 1129928,
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "auditorfirmid": 1263,
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "Calgary, Canada",
    "cashandcashequivalents": 31102844,
    "othercurrentreceivables": 866055,
    "currentprepaidexpenses": 2775800,
    "currentassets": 44903899,
    "propertyplantandequipment": 100663,
    "rightofuseassets": 584251,
    "assets": 45880191,
    "tradeandothercurrentpayables": 886891,
    "othercurrentliabilities": 277866,
    "currentleaseliabilities": 293672,
    "currentderivativefinancialliabilities": 56017,
    "currentliabilities": 2689838,
    "noncurrentcontractliabilities": 6730287,
    "noncurrentleaseliabilities": 361081,
    "liabilities": 9781206,
    "issuedcapital": 391348183,
    "warrantsandrightsoutstanding": 3617570,
    "additionalpaidincapital": 34161103,
    "accumulatedothercomprehensiveincome": 387738,
    "retainedearnings": -393415609,
    "equity": 391348183,
    "equityandliabilities": 45880191,
    "numberofsharesissued": 55043789,
    "researchanddevelopmentexpense": 12920371,
    "operatingexpense": 13314574,
    "profitlossfromoperatingactivities": -26234945,
    "gainslossesonchangeinfairvalueofderivatives": -17117,
    "gainslossesonexchangedifferencesontranslationrecognisedinprofitorloss": -135636,
    "interestincomeoncashandcashequivalents": 98612,
    "profitlossbeforetax": -26254852,
    "incometaxexpensecontinuingoperations": 49427,
    "profitloss": -26304279,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": -12487,
    "comprehensiveincome": -26304279,
    "basicearningslosspershare": -0.49,
    "dilutedearningslosspershare": -0.49,
    "weightedaverageshares": 53513225,
    "adjustedweightedaverageshares": 53513225,
    "increasedecreasethroughexerciseofoptions": 238450,
    "increasedecreasethroughincentiveshareawardsequity": -543833,
    "issueofequity": 686616,
    "increasedecreasethroughexerciseofwarrantsequity": 686616,
    "increasedecreasethroughsharebasedpaymenttransactions": 3825901,
    "shareissuerelatedcost": 548859,
    "adjustmentsfordepreciationandamortisationexpense": 130243,
    "adjustmentsfordepreciationrightofuseassets": 321822,
    "adjustmentsforsharebasedpayments": 3825901,
    "interestexpenseonleaseliabilities": 91727,
    "adjustmentsforunrealisedforeignexchangelossesgains": 425681,
    "increasedecreaseinworkingcapital": 907987,
    "cashflowsfromusedinoperations": -22434009,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 285948,
    "cashflowsfromusedininvestingactivities": -285948,
    "proceedsfromexerciseofoptions": 238450,
    "proceedsfromissuingshares": 32911791,
    "cashoutflowforleases": 365510,
    "cashflowsfromusedinfinancingactivities": 33015677,
    "increasedecreaseincashandcashequivalents": 10295720,
    "effectofexchangeratechangesoncashandcashequivalents": -253250,
    "propertyplantandequipmentannualdepreciationrate": 0.3,
    "numberofstockoptionplans": 1,
    "maximumtermofoptionsgrantedforsharebasedpaymentarrangement": 10,
    "cashequivalents": 39901509,
    "cashequivalentsinterestrate": 0.0045000000000000005,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 285620,
    "depreciationpropertyplantandequipment": 130243,
    "disposalspropertyplantandequipment": -650700,
    "operatingleaseremainingleaseterm": 6,
    "weightedaveragelesseesincrementalborrowingrateappliedtoleaseliabilitiesrecognisedatdateofinitialapplicationofifrs16": 0.15,
    "additionstorightofuseassets": 208976,
    "leasemodificationrightofuseassets": 323782,
    "depreciationrightofuseassets": 321822,
    "foreignexchangeimpactrightofuseassets": 847,
    "leaseliabilities": 654753,
    "increasethroughnewleasesliabilitiesarisingfromfinancingactivities": 203868,
    "effectofleasemodificationonleaseliabilities": 323782,
    "gainslossesfromforeignexchangeimpact": -2424,
    "grossleaseliabilities": 807643,
    "issueofequityshares": 2715932,
    "sharesissuedpricepershare1": 3.19,
    "grossproceedsfromissueofordinaryshares": 8654892,
    "proceedsfromwarrantexercises1": 181550,
    "classofwarrantorrightoutstanding1": 64035,
    "classofwarrantorrightnumberofwarrantsexercised": 201722,
    "warrantsandrightsoutstanding1": 3617570,
    "classofwarrantorrightwarrantsexercised": 455670,
    "fairvalueofwarrantissuedperwarrant": 0.69,
    "warrantissuedunderlyingshareprice": 1.39,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.006600000000000001,
    "descriptionofoptionlifeshareoptionsgranted": 3,
    "descriptionofexpectedvolatilityshareoptionsgranted": 1.1045,
    "shareissuerelatedcostcommissions": 259647,
    "proceedsfromissueofordinaryshares": 8395245,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights1": 1730894,
    "numberofsharesoutstanding": 16443500,
    "numberofoutstandingshareoptions": 128618,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 1832500,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": 110612,
    "numberofshareoptionsexpiredinsharebasedpaymentarrangement": 28364,
    "numberofshareoptionsexercisedinsharebasedpaymentarrangement": 123159,
    "numberofshareoptionsexercisableinsharebasedpaymentarrangement": 128618,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 20.8,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 2.99,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement2019": 6.21,
    "weightedaverageexercisepriceofshareoptionsexpiredinsharebasedpaymentarrangement2019": 37.63,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentarrangement2019": 1.94,
    "weightedaverageexercisepriceofshareoptionsexercisableinsharebasedpaymentarrangement2019": 20.8,
    "exercisepriceofoutstandingshareoptions2019": 40,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": 3.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "three-year",
    "sharebasedcompensationarrangementbysharebasedpaymentawardcliffawardvestingperiod": 3,
    "sharesreservedforissueunderoptionsandcontractsforsaleofshares": 5504379,
    "expensefromsharebasedpaymenttransactionswithemployees": 1739293,
    "weightedaveragefairvalueatmeasurementdateshareoptionsgranted": 1.99,
    "numberofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement": 40560,
    "numberofotherequityinstrumentsexercisedorvestedinsharebasedpaymentarrangement": 56841,
    "contractliabilityrecognitionperiod": "five years",
    "contractliabilities": 6730287,
    "purchaseobligation1": 21516576,
    "purchaseobligationcommitmentterm": "three years",
    "otherreceivables": 621746,
    "fundedandroyaltyrepayment": 400000,
    "overheadrepayment": 100000,
    "annualcontingentpaymentgrosssalespercent": 0.05,
    "annualcontingentpayment": 100000,
    "commitmentsmadebyentityrelatedpartytransactions": 1000000,
    "commitmentsmadebyentityrelatedpartytransactionsperioddue": 90,
    "commitmentsmadebyentityrelatedpartytransactionsroyaltypaymentreceivedpercentage": 0.1075,
    "commitmentsmadebyentityrelatedpartytransactionsroyaltypaymentnetsalespercentage": 0.0215,
    "contingentroyaltypaymentpercentofsalesrevenue": 0.005,
    "contingentroyaltypaymentannualmaximum": 20000,
    "accountingprofit": -26254852,
    "applicabletaxrate": 0.23,
    "taxexpenseincomeatapplicabletaxrate": -6038616,
    "taxeffectofforeigntaxrates": 2716319,
    "taxeffectofstockbasedcompensation": -879957,
    "taxeffectofchangeinfairvalueofwarrantderivative": -3937,
    "taxeffectoftaxpools": -552079,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": 44290,
    "taxeffectofexpirationoftaxbenefits": 1661187,
    "valuationallowancedeferredtaxassetincreasedecreaseamount1": -1342306,
    "currenttaxexpenseincome": 49427,
    "unusedtaxcreditsforwhichnodeferredtaxassetrecognised": 1343000,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 162986000,
    "deductibletemporarydifferencesforwhichnodeferredtaxassetisrecognised": 37583775,
    "sensitivityanalysisfortypesofmarketriskreasonablypossiblechangeinriskvariableamount": 0.01,
    "sensitivityanalysisfortypesofmarketriskreasonablypossiblechangeinriskvariableimpactonpretaxearnings": -240000,
    "balanceheldinforeigncurrencynet": 30837699,
    "adjustmentsfordecreaseincreaseinotheroperatingreceivables": -776394,
    "adjustmentsfordecreaseincreaseinprepaidexpenses": -348600,
    "adjustmentsforincreasedecreaseintradeandotherpayables": 182855,
    "adjustmentsforincreasedecreaseinotheroperatingpayables": 228294,
    "increasedecreasethroughforeignexchangefinancialassetsliabilitiesnet": -194142,
    "proceedsfrominterestreceived": 190339,
    "incometaxespaidrefund": 34959,
    "concentrationrisknumber": 1,
    "employeebenefitsexpense": 2542210,
    "amortisationexpense": 130243,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 3918564,
    "keymanagementpersonnelcompensationsharebasedpayment": 2703256,
    "keymanagementpersonnelcompensation": 6621820
  },
  {
    "date": "2020-12-31",
    "symbol": "ONCY",
    "period": "FY",
    "entityregistrantname": "ONCOLYTICS BIOTECH INC",
    "entitycentralindexkey": 1129928,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Accelerated Filer",
    "documenttype": "20-F",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "entitycommonstocksharesoutstanding": 46166980,
    "icfrauditorattestationflag": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "false",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "cashandcashequivalents": 31219574,
    "othercurrentreceivables": 89661,
    "currentprepaidexpenses": 2427200,
    "currentassets": 33736435,
    "propertyplantandequipment": 236664,
    "rightofuseassets": 372468,
    "noncurrentassets": 609132,
    "assets": 34345567,
    "tradeandothercurrentpayables": 1805015,
    "othercurrentliabilities": 123985,
    "currentleaseliabilities": 248885,
    "currentderivativefinancialliabilities": 531228,
    "currentliabilities": 2709113,
    "noncurrentcontractliabilities": 6730287,
    "noncurrentleaseliabilities": 153174,
    "noncurrentliabilities": 6883461,
    "liabilities": 9592574,
    "issuedcapital": 356824172,
    "warrantsandrightsoutstanding": 3617570,
    "additionalpaidincapital": 31022356,
    "accumulatedothercomprehensiveincome": 400225,
    "retainedearnings": -367111330,
    "equity": 24752993,
    "equityandliabilities": 34345567,
    "numberofsharesissued": 46166980,
    "researchanddevelopmentexpense": 12944510,
    "operatingexpense": 12514496,
    "profitlossfromoperatingactivities": -25459006,
    "gainslossesonchangeinfairvalueofderivatives": 3491928,
    "gainslossesonexchangedifferencesontranslationrecognisedinprofitorloss": -659173,
    "interestincomeoncashandcashequivalents": 121194,
    "profitlossbeforetax": -22505057,
    "profitloss": -22505057,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": -63876,
    "comprehensiveincome": -22568933,
    "basicanddilutedearningslosspershare": -0.56,
    "weightedaverageshares": 40338789,
    "adjustedweightedaverageshares": 40338789,
    "increasedecreasethroughincentiveshareawardsequity": 732367,
    "increasedecreasethroughexerciseofoptions": 385022,
    "issueofequity": 40037786,
    "increasedecreasethroughexerciseofwarrantsequity": 6332778,
    "increasedecreasethroughsharebasedpaymenttransactions": 2558974,
    "shareissuerelatedcost": 1741640,
    "adjustmentsfordepreciationandamortisationexpense": 88957,
    "depreciationrightofuseassets": 357230,
    "adjustmentsforsharebasedpayments": 2558974,
    "interestexpenseonleaseliabilities": 68526,
    "adjustmentsforunrealisedforeignexchangelossesgains": 645078,
    "increasedecreaseinworkingcapital": -209779,
    "cashflowsfromusedinoperations": -22068441,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 29305,
    "cashflowsfromusedininvestingactivities": -29305,
    "proceedsfromexerciseofoptions": 241922,
    "proceedsfromissuingshares": 1696460,
    "cashoutflowforleases": 460724,
    "cashflowsfromusedinfinancingactivities": 39773804,
    "increasedecreaseincashandcashequivalents": 17676058,
    "effectofexchangeratechangesoncashandcashequivalents": -604505,
    "propertyplantandequipmentannualdepreciationrate": 0.2,
    "numberofstockoptionplans": 1,
    "maximumtermofoptionsgrantedforsharebasedpaymentarrangement": "P10Y",
    "cashequivalents": 30361591,
    "cashequivalentsinterestrate": 0.0036,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 1134,
    "disposalspropertyplantandequipment": 15137,
    "depreciationpropertyplantandequipment": 2942,
    "operatingleaseremainingleaseterm": "P3Y",
    "weightedaveragelesseesincrementalborrowingrateappliedtoleaseliabilitiesrecognisedatdateofinitialapplicationofifrs16": 0.15,
    "numberofrenewals": 1,
    "foreignexchangeimpactrightofuseassets": 1612,
    "additionstorightofuseassets": 297373,
    "leaseliabilities": 402059,
    "increasethroughnewleasesliabilitiesarisingfromfinancingactivities": 297373,
    "gainslossesfromforeignexchangeimpact": -9391,
    "grossleaseliabilities": 286509,
    "issueofequityshares": 133454,
    "sharesissuedpricepershare1": 2.42,
    "grossproceedsfromissueofordinaryshares": 17538342,
    "proceedsfromwarrantexercises1": 1276532,
    "classofwarrantorrightoutstanding1": 265757,
    "classofwarrantorrightnumberofwarrantsexercised": 1418369,
    "warrantsandrightsoutstanding1": 531228,
    "classofwarrantorrightwarrantsexercised": 4636317,
    "fairvalueofwarrantissuedperwarrant": 1.57,
    "warrantissuedunderlyingshareprice": 2.38,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.001,
    "descriptionofoptionlifeshareoptionsgranted": 1,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.9,
    "shareissuerelatedcostcommissions": 526150,
    "proceedsfromissueofordinaryshares": 17012192,
    "numberofsharesoutstanding": 16443500,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights1": 1730894,
    "numberofoutstandingshareoptions": 3764055,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 1817500,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": 141418,
    "numberofshareoptionsexpiredinsharebasedpaymentarrangement": 25520,
    "numberofshareoptionsexercisedinsharebasedpaymentarrangement": 133454,
    "numberofshareoptionsexercisableinsharebasedpaymentarrangement": 2164551,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 4.08,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 3.19,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement2019": 3.84,
    "weightedaverageexercisepriceofshareoptionsexpiredinsharebasedpaymentarrangement2019": 62.49,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentarrangement2019": 1.81,
    "weightedaverageexercisepriceofshareoptionsexercisableinsharebasedpaymentarrangement2019": 4.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P1Y",
    "sharesreservedforissueunderoptionsandcontractsforsaleofshares": 4616698,
    "expensefromsharebasedpaymenttransactionswithemployees": 2558974,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": "P3Y10D",
    "exercisepriceofoutstandingshareoptions2019": 0.54,
    "expectedforfeitureshareoptionsgranted": 0.0367,
    "weightedaveragefairvalueatmeasurementdateshareoptionsgranted": 2.12,
    "numberofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement": 134618,
    "numberofinstrumentsotherequityinstrumentsgranted": 154923,
    "numberofotherequityinstrumentsexercisedorvestedinsharebasedpaymentarrangement": 229962,
    "weightedaveragefairvalueatmeasurementdateotherequityinstrumentsgranted": 2.41,
    "contractliabilityrecognitionperiod": 5,
    "contractliabilities": 6730287,
    "purchaseobligation1": 9360653,
    "purchaseobligationcommitmentterm": "P2Y",
    "fundedandroyaltyrepayment": 400000,
    "overheadrepayment": 100000,
    "annualcontingentpaymentgrosssalespercent": 0.05,
    "annualcontingentpayment": 100000,
    "commitmentsmadebyentityrelatedpartytransactions": 1000000,
    "commitmentsmadebyentityrelatedpartytransactionsperioddue": "P90D",
    "commitmentsmadebyentityrelatedpartytransactionsroyaltypaymentreceivedpercentage": 0.1075,
    "commitmentsmadebyentityrelatedpartytransactionsroyaltypaymentnetsalespercentage": 0.0215,
    "contingentroyaltypaymentpercentofsalesrevenue": 0.005,
    "contingentroyaltypaymentannualmaximum": 20000,
    "accountingprofit": -22505057,
    "applicabletaxrate": 0.24,
    "taxexpenseincomeatapplicabletaxrate": -5401214,
    "taxeffectofforeigntaxrates": 3237898,
    "taxeffectofstockbasedcompensation": -614154,
    "taxeffectofchangeinfairvalueofwarrantderivative": -838063,
    "taxeffectfromchangeintaxrate": 96028,
    "taxeffectoftaxpools": 20711,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": 108945,
    "valuationallowancedeferredtaxassetincreasedecreaseamount1": -2161541,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 9809000,
    "unusedtaxcreditsforwhichnodeferredtaxassetrecognised": 471000,
    "deductibletemporarydifferencesforwhichnodeferredtaxassetisrecognised": 21487804,
    "sensitivityanalysisfortypesofmarketriskreasonablypossiblechangeinriskvariableamount": 0.01,
    "sensitivityanalysisfortypesofmarketriskreasonablypossiblechangeinriskvariableimpactonpretaxearnings": -172000,
    "balanceheldinforeigncurrencynet": 22261287,
    "adjustmentsfordecreaseincreaseinotheroperatingreceivables": 1979111,
    "increasedecreaseinprepaidexpense1": 286391,
    "adjustmentsforincreasedecreaseintradeandotherpayables": -1368203,
    "adjustmentsforincreasedecreaseinotheroperatingpayables": -723230,
    "increasedecreasethroughforeignexchangefinancialassetsliabilitiesnet": 35710,
    "proceedsfrominterestreceived": 189720,
    "incometaxespaidrefund": 12080,
    "concentrationrisknumber": 1,
    "amortisationexpense": 88957,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 3514527,
    "keymanagementpersonnelcompensationterminationbenefits": 495175,
    "keymanagementpersonnelcompensationsharebasedpayment": 1757723,
    "keymanagementpersonnelcompensation": 5767425
  },
  {
    "date": "2019-12-31",
    "symbol": "ONCY",
    "period": "FY",
    "adjustmentsfordecreaseincreaseinotheroperatingreceivables": -2017122,
    "increasedecreaseinprepaidexpense1": -2012605,
    "adjustmentsforincreasedecreaseintradeandotherpayables": 1347365,
    "adjustmentsforincreasedecreaseinotheroperatingpayables": 807877,
    "increasedecreasethroughforeignexchangefinancialassets": 78708,
    "increasedecreaseinworkingcapital": 1795777,
    "proceedsfrominterestreceived": 274094,
    "incometaxespaidrefund": 5448,
    "cashandcashequivalents": 9676360,
    "equity": 3617570,
    "cashequivalents": 13058092,
    "cashequivalentsinterestrate": 0.0117,
    "purchaseobligation1": 4867131,
    "otherreceivables": 1500000,
    "othercurrentliabilities": 652306,
    "fundedandroyaltyrepayment": 400000,
    "overheadrepayment": 100000,
    "annualcontingentpaymentgrosssalespercent": 0.05,
    "annualcontingentpayment": 100000,
    "profitloss": -33122888,
    "adjustmentsfordepreciationandamortisationexpense": 122982,
    "depreciationrightofuseassets": 362592,
    "adjustmentsforsharebasedpayments": 1470153,
    "interestexpenseonleaseliabilities": 94817,
    "adjustmentsforunrealisedforeignexchangelossesgains": 356081,
    "gainslossesonchangeinfairvalueofderivatives": -12608808,
    "cashflowsfromusedinoperations": -19906124,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 10905,
    "cashflowsfromusedininvestingactivities": -10905,
    "proceedsfromissuingshares": 3465867,
    "cashoutflowforleases": 447497,
    "cashflowsfromusedinfinancingactivities": 21015596,
    "increasedecreaseincashandcashequivalents": 1098567,
    "effectofexchangeratechangesoncashandcashequivalents": -650427,
    "comprehensiveincome": -33122888,
    "increasedecreasethroughincentiveshareawardsequity": -391917,
    "issueofequity": 5403385,
    "increasedecreasethroughexerciseofwarrantsequity": 9152869,
    "increasedecreasethroughsharebasedpaymenttransactions": 1470153,
    "shareissuerelatedcost": 344834,
    "othercurrentreceivables": 1500000,
    "currentprepaidexpenses": 2713591,
    "currentassets": 18930384,
    "propertyplantandequipment": 15670,
    "rightofuseassets": 430713,
    "noncurrentassets": 727481,
    "assets": 19657865,
    "tradeandothercurrentpayables": 1378860,
    "currentleaseliabilities": 339846,
    "currentderivativefinancialliabilities": 6551250,
    "currentliabilities": 12869043,
    "noncurrentcontractliabilities": 6730287,
    "noncurrentleaseliabilities": 166429,
    "noncurrentliabilities": 6896716,
    "liabilities": 19765759,
    "issuedcapital": 311077859,
    "warrantsandrightsoutstanding": 3617570,
    "additionalpaidincapital": 29338849,
    "accumulatedothercomprehensiveincome": 464101,
    "retainedearnings": -344606273,
    "equityandliabilities": 19657865,
    "numberofsharesissued": 16443500,
    "researchanddevelopmentexpense": 11134716,
    "operatingexpense": 9558641,
    "profitlossfromoperatingactivities": -20693357,
    "interestincomeoncashandcashequivalents": 179277,
    "profitlossbeforetax": -33122888,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": -143403,
    "basicanddilutedearningslosspershare": -1.5,
    "weightedaverageshares": 22137990,
    "adjustedweightedaverageshares": 22137990,
    "commitmentsmadebyentityrelatedpartytransactions": 1000000,
    "commitmentsmadebyentityrelatedpartytransactionsperioddue": "P90D",
    "commitmentsmadebyentityrelatedpartytransactionsroyaltypaymentreceivedpercentage": 0.1075,
    "commitmentsmadebyentityrelatedpartytransactionsroyaltypaymentnetsalespercentage": 0.0215,
    "contingentroyaltypaymentpercentofsalesrevenue": 0.005,
    "contingentroyaltypaymentannualmaximum": 20000,
    "contingentroyaltypaymentcontributionrate": 2,
    "accruedroyalties1": 301000,
    "contractliabilities": 6730287,
    "entityregistrantname": "ONCOLYTICS BIOTECH INC",
    "entitycentralindexkey": 1129928,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "documenttype": "20-F",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "entitycommonstocksharesoutstanding": 32198453,
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "false",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "concentrationrisknumber": 1,
    "sensitivityanalysisfortypesofmarketriskreasonablypossiblechangeinriskvariableamount": 0.01,
    "sensitivityanalysisfortypesofmarketriskreasonablypossiblechangeinriskvariableimpactonpretaxearnings": 125339,
    "balanceheldinforeigncurrencynet": 3246250,
    "accountingprofit": -33122888,
    "applicabletaxrate": 0.265,
    "taxexpenseincomeatapplicabletaxrate": -8777565,
    "taxeffectofforeigntaxrates": 3088811,
    "taxeffectofstockbasedcompensation": -389591,
    "taxeffectofchangeinfairvalueofwarrantderivative": 3341334,
    "taxeffectfromchangeintaxrate": 3758175,
    "taxeffectoftaxpools": 11973,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": 149294,
    "valuationallowancedeferredtaxassetincreasedecreaseamount1": 1961613,
    "deductibletemporarydifferencesforwhichnodeferredtaxassetisrecognised": 19625642,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 69230000,
    "unusedtaxcreditsforwhichnodeferredtaxassetrecognised": 27560000,
    "operatingleaseremainingleaseterm": "P3Y",
    "weightedaveragelesseesincrementalborrowingrateappliedtoleaseliabilitiesrecognisedatdateofinitialapplicationofifrs16": 0.15,
    "foreignexchangeimpactrightofuseassets": -14720,
    "leaseliabilities": 506275,
    "gainslossesfromforeignexchangeimpact": -23482,
    "grossleaseliabilities": 391022,
    "gainslossesonexchangedifferencesontranslationrecognisedinprofitorloss": 39362,
    "expensefromsharebasedpaymenttransactionswithemployees": 561420,
    "amortisationexpense": 122982,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 7014,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 3786667,
    "keymanagementpersonnelcompensationsharebasedpayment": 1123408,
    "keymanagementpersonnelcompensation": 4910075,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.0159,
    "descriptionofoptionlifeshareoptionsgranted": 3,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.979,
    "expectedforfeitureshareoptionsgranted": 0.0367,
    "weightedaveragefairvalueatmeasurementdateshareoptionsgranted": 0.87,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": 3,
    "sharesreservedforissueunderoptionsandcontractsforsaleofshares": 3219845,
    "numberofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement": 209657,
    "numberofinstrumentsotherequityinstrumentsgranted": 270098,
    "numberofotherequityinstrumentsexercisedorvestedinsharebasedpaymentarrangement": 321196,
    "weightedaveragefairvalueatmeasurementdateotherequityinstrumentsgranted": 0.8,
    "numberofoutstandingshareoptions": 900000,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 1020000,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": 12839,
    "numberofshareoptionsexpiredinsharebasedpaymentarrangement": 9575,
    "numberofshareoptionsexercisableinsharebasedpaymentarrangement": 300009,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 1.45,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 1.42,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement2019": 11.35,
    "weightedaverageexercisepriceofshareoptionsexpiredinsharebasedpaymentarrangement2019": 29.07,
    "weightedaverageexercisepriceofshareoptionsexercisableinsharebasedpaymentarrangement2019": 1.45,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": "P4Y11M12D",
    "exercisepriceofoutstandingshareoptions2019": 1.79,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights1": 1730894,
    "issueofequityshares": 4425040,
    "grossproceedsfromissueofordinaryshares": 6390691,
    "exercisepriceofoutstandingwarrants": 9.025,
    "numberofstockoptionplans": 1,
    "maximumtermofoptionsgrantedforsharebasedpaymentarrangement": "P10Y",
    "propertyplantandequipmentannualdepreciationrate": 0.2,
    "classofwarrantorrightoutstanding1": 1684126,
    "warrantsandrightsoutstanding1": 8508764,
    "fairvalueofwarrantissuedperwarrant": 3.89
  }
]